
Sign up to save your podcasts
Or


This week on BioTech Nation, Dr. Peter Vanderklish, Chief Scientific Officer at Spinogenix discusses their clinical trials focused on regenerating synapses to repair brain connections and offer hope for conditions like Alzheimer's, ALS, schizophrenia and depression. Phase 2 trials are underway. Check their website for patient recruitment information.
By Moira Gunn4.1
2929 ratings
This week on BioTech Nation, Dr. Peter Vanderklish, Chief Scientific Officer at Spinogenix discusses their clinical trials focused on regenerating synapses to repair brain connections and offer hope for conditions like Alzheimer's, ALS, schizophrenia and depression. Phase 2 trials are underway. Check their website for patient recruitment information.

21,968 Listeners

43,850 Listeners

32,012 Listeners

30,699 Listeners

43,592 Listeners

707 Listeners

6,409 Listeners

30,219 Listeners

125 Listeners

320 Listeners

9,904 Listeners

34 Listeners

18 Listeners

48 Listeners

138 Listeners